🇺🇸 FDA
Patent

US 11654128

Methods and compositions for treating ectoparasite infestations

granted A61KA61K31/23A61K31/80

Quick answer

US patent 11654128 (Methods and compositions for treating ectoparasite infestations) held by Nuvo Pharmaceuticals (Ireland) Designated Activity Company expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nuvo Pharmaceuticals (Ireland) Designated Activity Company
Grant date
Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/23, A61K31/80, A61P, A61P33/14